Extract from the Register of European Patents

EP About this file: EP2307354

EP2307354 - PROCESS FOR PREPARING A BENZOYLBENZENEACETAMIDE DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2013
Database last updated on 14.03.2026
Most recent event   Tooltip30.05.2014Lapse of the patent in a contracting state
New state(s): LU
published on 02.07.2014  [2014/27]
Applicant(s)For all designated states
Medichem, S.A.
Fructuós Gelabert 6-8 Sant Joan Despi
08970 Barcelona / ES
[2011/15]
Inventor(s)01 / TOJO SUÁREZ, Gabriel
Lugar da Pia
Biduido de Arriba 30
E-15895 Ames / ES
02 / GAVALDÁ ESCUDÉ, Ana
Avinguda de Villadelprat 23B
E-08173 Sant Cugat del Valles / ES
 [2012/17]
Former [2011/15]01 / TOJO SUÁREZ, Gabriel
Lugar da Pia Biduido de Arriba 30
E-15895 Ames / ES
02 / GAVALDÁ ESCUDÉ, Ana
Avinguda de Villadelprat 23B
E-08173 Sant Cugat del Valles / ES
Representative(s)Illescas, Manuel
GONZÁLEZ-BUENO & ILLESCAS
Calle de Recoletos, 13 - 5 lzq.
28001 Madrid / ES
[N/P]
Former [2012/17]Illescas, Manuel
GONZÁLEZ-BUENO & ILLESCAS Calle de Recoletos, 13 - 5 lzq.
28001 Madrid / ES
Former [2011/15]Illescas, Manuel
GONZÁLEZ-BUENO & ILLESCAS Calle de Recoletos, 13 - 5 lzq.
28001 Madrid / ES
Application number, filing date09762052.012.06.2009
[2011/15]
WO2009IB05918
Priority number, dateUS20080061215P13.06.2008         Original published format: US 61215 P
US20080117834P25.11.2008         Original published format: US 117834 P
[2011/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009150524
Date:17.12.2009
Language:EN
[2009/51]
Type: A1 Application with search report 
No.:EP2307354
Date:13.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2009 takes the place of the publication of the European patent application.
[2011/15]
Type: B1 Patent specification 
No.:EP2307354
Date:25.04.2012
Language:EN
[2012/17]
Search report(s)International search report - published on:EP17.12.2009
ClassificationIPC:C07C233/33, C07C323/60, A61K31/165, A61P7/02
[2011/15]
CPC:
C07C319/20 (EP,US); A61P7/02 (EP); C07C237/20 (EP,US);
C07C323/60 (EP,US)
C-Set:
C07C319/20, C07C323/60 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/15]
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINES BENZOYLBENZOLACETAMIDDERIVATS[2011/15]
English:PROCESS FOR PREPARING A BENZOYLBENZENEACETAMIDE DERIVATIVE[2011/15]
French:PROCÉDÉ DE PRÉPARATION D UN DÉRIVÉ DE BENZOYLBENZÈNE ACÉTAMIDE[2011/15]
Entry into regional phase10.01.2011National basic fee paid 
10.01.2011Designation fee(s) paid 
10.01.2011Examination fee paid 
Examination procedure10.01.2011Examination requested  [2011/15]
19.04.2011Amendment by applicant (claims and/or description)
28.02.2012Communication of intention to grant the patent
08.03.2012Fee for grant paid
08.03.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.02.2012
Opposition(s)28.01.2013No opposition filed within time limit [2013/14]
Fees paidRenewal fee
27.06.2011Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MK25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
TR25.04.2012
IE12.06.2012
LU12.06.2012
MC30.06.2012
BG25.07.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
[2014/27]
Former [2014/21]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MK25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
TR25.04.2012
IE12.06.2012
MC30.06.2012
BG25.07.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/34]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MK25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
IE12.06.2012
MC30.06.2012
BG25.07.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/20]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MK25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
IE12.06.2012
MC30.06.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/12]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MK25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
MC30.06.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/10]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
MC30.06.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/09]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
MC30.06.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/08]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
MC30.06.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/07]AT25.04.2012
BE25.04.2012
CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/04]BE25.04.2012
CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/01]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2012/51]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
Former [2012/50]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
NO25.07.2012
GR26.07.2012
IS25.08.2012
Former [2012/49]CY25.04.2012
FI25.04.2012
LT25.04.2012
PL25.04.2012
SE25.04.2012
NO25.07.2012
IS25.08.2012
Former [2012/48]FI25.04.2012
LT25.04.2012
SE25.04.2012
NO25.07.2012
Former [2012/47]LT25.04.2012
NO25.07.2012
Cited inInternational search[XA]   D.A. WALSH ET. AL.: "Antiinflammatory Agents. 4. Synthesis and Biological Evaluation of Potential Prodrugs of 2-Amino-3-benzoylbenzeneacetic Acid and 2-Amino-3-(4-chlorobenzoyl)benzeneacetic Acid.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 8, 1990, pages 2296 - 2304, XP002544459 [X] 13,21 * page 2297, scheme 1; page 2302, column 1, paragraph 6. * [A] 1-12,14-20

DOI:   http://dx.doi.org/10.1021/jm00170a039
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.